ARTICLE | Clinical News
Otezla Apremilast regulatory update
February 9, 2015 8:00 AM UTC
The European Commission approved Otezla apremilast from Celgene to treat active psoriatic arthritis and moderate to severe chronic plaque psoriasis in adult patients. The company plans to launch the o...